Mosaic Enterprise caters for more complex integration needs with direct integration for liquid handlers, higher use of automation and/or multiple site operations.
Key features:
Multiple Zones
Sample Pickup and Drop Off
Partner Portal
Assay Requesting
Inter-Organisation Connectors
Integrations:
Liquid Handlers and Robotic Platforms
Automated Stores
Ideal for labs requiring automation, integration or scalability across global networks.
"First it helps us in our daily work at BioAscent. Without Titian’s Mosaic we would probably need more people. Also, it’s been quite a good tool to sell the service. Titian’s Mosaic is well established and it’s a guarantee of quality." Dr Sylviane Boucharens, BioAscent, Co-founder and Chief Operating Officer
“It’s clear for me, Mosaic is the number one asset of the value proposition when we discuss compound management with clients.
For a client, if he says two years later ‘there is something wrong with this plate’ – we are able to come back to that run and know exactly if the run was interrupted.
That audit trail for us is very, very essential. Even if it is not routinely used, the client knows he can refer to it. It’s very positive for him."
Dr Sylviane Boucharens, Co-founder and Chief Operating Officer, BioAscent
"Titian Mosaic manages our high throughput screening library which is run at 860,000 compounds and we use it to interface with a range of instrumentation from the Labcyte Echo platform, we have some mosquito instruments and also some BioCels, Platemates and CyBios. A whole range of liquid handling platforms completely for managing our high throughput screening deck.
We have a number of other data management tools within the organisation, there’s the chemical registration system which Titian Mosaic directly interfaces with. From a screening data perspective we use ActivityBase from IDBS and Genedata Screener software and we have interfaces that link all those packages together to track the samples.”
David Cronk - Charles River Laboratories
"We have worked with Mosaic for the last 5 or 6 years, there are 2 features that stand out to us.
One is the simplicity of ordering, so our scientist or our people who work in sample management can place orders for compounds very straightforwardly.
The 2nd is the robotic integration, so the execution of that order happens completely in the background, our people do not have to interact with many different types of automation in order to create the final compound plate."
Clive Green - AstraZeneca